ZAGREB, 10 Nov (Hina) - Croatia is entering the final phase of establishing domestic production of cell immunotherapy for the treatment of leukemia, lymphoma and autoimmune diseases, with the first patients expected to receive the therapy as early as mid-2026, it was announced on Monday at Zagreb's Children's Hospital.
Only logged-in users can see full content details
(Hina) rml